Observational studies have demonstrated that ACSL4 mRNA expression is inversely correlated with ER, AR and HER2 expression in both breast cancer cell lines and tumor samples, and is most highly expressed in TNBCs that fall into the category of claudin-low and basal-like cancers [24]. The gene discussed is ACSL4; the disease is cancer.